Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists

VMD - Viemed Healthcare Inc Stock Price, Fair Value and News

$6.76+0.11 (+1.65%)
Delayed
Max Portfolio Pct.
Check
Valuation
Check

Stock Quality:

GPSDBMFI
Max Portfolio Pct.
Check
Valuation
Check
GPSDBMFI

VMD Price Action

Last 7 days

-1.7%

Last 30 days

2.9%

Last 90 days

-0.9%

Trailing 12 Months

-22.3%

VMD RSI Chart

MarAprMayJunJulAugSepOctNovDec102030405060708090

VMD Valuation

Market Cap

257.0M

Price/Earnings (Trailing)

18.65

Price/Sales (Trailing)

1.01

EV/EBITDA

11.91

Price/Free Cashflow

47.73

VMD Price/Sales (Trailing)

20232024202511.522.53

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

VMD Fundamentals

VMD Revenue

Revenue (TTM)

254.8M

Rev. Growth (Yr)

23.98%

Rev. Growth (Qtr)

14.05%

202020222024100M150M200M250M

VMD Earnings

Earnings (TTM)

13.8M

Earnings Growth (Yr)

-7.17%

Earnings Growth (Qtr)

14.03%

20192020202120222023202420255M10M15M20M25M30M

VMD Profitability

EBT Margin

7.88%

Return on Equity

10.17%

Return on Assets

6.81%

Free Cashflow Yield

2.1%

VMD Investor Care

Buy Backs (1Y)

2.36%

Diluted EPS (TTM)

0.34

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2025232.8M240.9M254.8M0
2024194.0M205.7M214.3M224.3M
2023146.1M156.1M169.8M183.0M
2022120.9M126.8M133.3M138.8M
2021135.9M120.5M116.3M117.1M
202085.9M108.5M121.6M131.3M
201968.6M73.7M77.2M80.3M
201800064.5M
Get all data in R, Python etc through our Historical Stock Data APIs

About Viemed Healthcare Inc

Viemed Healthcare, Inc., through its subsidiaries, provides in-home durable medical equipment (DME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company also leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), percussion vests, oxygen concentrator units, and other small respiratory equipment; and sells and rents DME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management related solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.
 CEO
 WEBSITEviemed.com
 SECTORHealthcare
 INDUSTRYMedical Devices
 EMPLOYEES974

Viemed Healthcare Inc Frequently Asked Questions

What is the ticker symbol for Viemed Healthcare Inc? What does VMD stand for in stocks?

VMD is the stock ticker symbol of Viemed Healthcare Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Viemed Healthcare Inc (VMD)?

As of Wed Dec 03 2025, market cap of Viemed Healthcare Inc is 257 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of VMD stock?

You can check VMD's fair value in chart for subscribers.

Is Viemed Healthcare Inc a good stock to buy?

The fair value guage provides a quick view whether VMD is over valued or under valued. Whether Viemed Healthcare Inc is cheap or expensive depends on the assumptions which impact Viemed Healthcare Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for VMD.

What is Viemed Healthcare Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, VMD's PE ratio (Price to Earnings) is 18.65 and Price to Sales (PS) ratio is 1.01. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. VMD PE ratio will change depending on the future growth rate expectations of investors.